Clinical trial · Interventional
The Use of a Quality of Life Questionnaire in Patients With Lung Cancer
A Prospective Randomised Controlled Study to Investigate the Effectiveness of Using a Quality of Life Questionnaire to Target Interventions to Improve Quality of Life in Patients With Lung Cancer
NCT01213745CI-TRIAL-00004044unknownN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study will investigate the effectiveness of using the European Organisation for Research and Treatment of cancer Core Quality of Life Questionnaire (EORTC QLQ-C30 + LC 13) to identify and target therapies in patients with lung cancer. The study will assess whether using the questionnaire will result in an improvement in QoL.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Lung Cancer | Malignant Lung Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (3)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Attention | Other | — | UNRESOLVED |
| Control | Other | — | UNRESOLVED |
| Intervention | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (3)
- type
- EXPERIMENTAL
- label
- Intervention
- interventionNames
- Other: Intervention
- type
- EXPERIMENTAL
- label
- Attention
- interventionNames
- Other: Attention
- type
- ACTIVE_COMPARATOR
- label
- Control
- interventionNames
- Other: Control
Primary outcomes (1)
- measure
- To investigate whether the use of QOL questionnaires during the assessment and management of lung cancer patients results in improved quality of life
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * male or female age \> 18 years * patients who are able to adequately understand written and spoken english * diagnosis of lung cancer (non small cell, small cell, mesothelioma) * no plan to commence treatment (chemotheraphy, targeted therapies, radioterhapy, surgery) with 6 weeks * both radically or palliatively treated patients remain eligible * patients whose toxicities from their primary treatment has resolved or have stabilised for a period of 7 days Exclusion Criteria: * patients are taking part on any other QoL studies * taking part in any other studies that requires QoL questionnaires, extra visits or investigations * currently on treatment (chemotherapy, radiotherapy, surgery or targeted therapies) * they have on going toxicities from their treatment which have not been stablised (required intervention within last 7 days)
References
Publications (1)
- DERIVEDNimako K, Ayite B, Priest K, Severn J, Fries HM, Gunapala R, Bhosle J, Popat S, O'Brien M. A randomised assessment of the use of a quality of life questionnaire with or without intervention in patients attending a thoracic cancer clinic. Eur J Cancer Care (Engl). 2017 Jul;26(4). doi: 10.1111/ecc.12402. Epub 2015 Nov 10. PMID 26556778